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Chronic  lymphocytic  leukemia  (CLL)  is  thought  to  be  a  malignancy  of bone 
marrow-derived  (B)  lymphocytes,  since  the  leukemic  cells  from  a  majority  of 
patients  bear  easily  detectable  membrane-bound  immunoglobulin  (Ig)  (1), 
possess a complement (C3) receptor (2),  and do not bind sheep erythrocytes (3). 
Since in most studies (1, 3-5), but not all (6), the cells from an individual patient 
bear  Ig  restricted  to  a  single  light  chain  class,  it  is  suspected  that  the  CLL 
lymphocytes represent the progeny of a  single clone of B cells. 
The present study provides support for the clonal proliferation of CLL cells by 
demonstrating  in  a  single  patient  that  the  Ig on  virtually  all  of the  CLL cells 
possess the  same  idiotypic  (variable  region)  determinants.  The  anti-idiotypic 
serum,  prepared  against  a  circulating  paraprotein,  reacted  only  with  the 
paraprotein  and the surface Ig on the CLL cells and not with a  variety of other 
serum or cell-bound Igs. 
Materials  and Methods 
Source and Isolation of Lymphocytes.  J.T. is a 61-yr old male with an 18 mo history of chronic 
lymphocytic  leukemia  and  an  |gG  paraprotein.  The  peripheral  lymphocyte  count  has  been 
maintained at _<  20,000 mature lymphocytes per mm  3  by two, brief courses of chemotherapy. The IgG 
paraprotein has persisted at 50-60 mg/ml throughout his course. 
Lymphocytes  were  collected  from  peripheral  blood  by  the  methods  of  BSyum  (7).  CLL 
lymphocytes from 23 different patients were either used fresh or frozen viably (8) and stored at -82°C 
for periods of up to 9 mo before use. Viability of the thawed cells ranged from 40-82%.  Preliminary 
experiments  demonstrated  that  viably  frozen  cells  maintained  their  surface  immunoglobulin. 
Lymphocytes (PBL) from 16 nonhematologic patients were used fresh. 
Purification  and  Characterization o/the Paraprotein and Preparation of Anti-ldiotypic Serum. 
The  paraprotein  was  purified  by  DEAE  chromatography and  preparative isoelectric focusing.  It 
was shown by double diffusion to possess kappa light chains; Dr. R. Wistar of the Naval Medical 
Research Institute, Bethesda, identified its subclass as IgG1. Heavy and light chains were separated 
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after reduction and alkylation; Fab fragments were prepared by papain digestion (9). Isolated chains 
were recombined by the method of Bridges and Little (10) and recombinant molecules isolated on 
Sephadex G-150 in phosphate-buffered saline. 
Anti-idiotypic serum was prepared in rabbits immunized with 1 mg of purified J. T.  IgG1 (K) 
emulsified in complete Freund's adjuvant  (Difco Laboratories, Detroit,  Mich.)  and  administered 
intraperitoneally. After 6 wk, the serum was collected and passed over an immunoadsorbent column 
of human 3,-globulin (HGG; CalBiochem, La Jolla, Calif.) coupled to Sepharose 4B (Sigma Chemical 
Co.,  St.  Louis,  Mo.)  by  cyanogen bromide.  The  specificity of the  absorbed antiserum and  the 
distribution of idiotypic determinants were determined by hemagglutination inhibition as described 
in Table I. 
Preparation  of  Class-Specific  Antisera  and  Fluorescent  Conjugates.  Class-specific,  purified 
antibodies were prepared by adsorption and acid elution from purified myeloma proteins conjugated 
to Sepharose. Goat antibody to IgD, sheep antibody to kappa and lambda light chains, IgE, and the 
Fab'2 fraction of IgG, and rabbit antibodies to IgM and IgA were prepared in this way. Certain of 
these antisera were kindly provided by Dr. H. Metzgar, NIH. In addition, antisera to IgG, IgA, IgM, 
and  IgD  were prepared as  described previously using  insoluble immunoadsorbents (11,  12).  The 
antisera  and  antibodies  were  conjugated  with  fluorescein  (Fl)  or tetramethylrhodamine  (Rh) 
isothiocyanate (13). 
Immunofluorescent  Labeling  of  Cells.  Lymphocytes  were  stained  with  Rh-  or  Fl-labeled 
antibodies or globulin fractions as previously described (11). Briefly, 1-3 × 10 ~  cells were incubated at 
4°C for 30 rain in 0.1  ml minimum essential medium (Grand Island Biological Co., Rockville, Md.) 
containing 50 ttg/ml of Rh- or Fl-labeled antibodies in 10% fetal calf serum. The cells were washed 
twice through fetal calf serum and suspended in medium containing 10 ttg/ml of ethidium bromide for 
5 min at room temperature. After a final wash the cells were examined with a fluorescent n~icroscope 
equipped for vertical illumination. Dead cells are stained homogeneously red with ethidium bromide 
and can be easily identified under these conditions. 
Results 
The specificity of the anti-idiotypic serum is shown in Table I. It is clear that a 
number of IgG myeloma proteins and normal Ig lack the idiotypic determinant(s) 
that J. T. IgG paraprotein possesses. In addition, the idiotypic determinants on 
J.  T.  IgG are located on the Fab  portion of the paraprotein, but not on either 
TABLE  I 
Specificity of Anti-Idiotypic  Serum 
Inhibitor  HI* 
ug/ml 
J. T. IgG(K)  0.18 (0.05-0.65)$ 
Fab  0.14 
Heavy chain  75 
Light chain  25 
Recombined heavy-light chain  0.86 
IgG myelomas  §  > 10,000 
Normal human serum  > 10,000 
Normal pooled Ig  > 10,000 
* Amount of protein which inhibits hemagglutination of J.  T.  IgG-coated sheep erythrocytes by a 
limiting dilution (1/300)  of anti-idiotypic antiserum. 
Geometric mean and SE of four determinations. 
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heavy or light chains alone. The unique specificity of the anti-idiotypic serum is 
supported by the fact that recombination of the heavy and light chains restores 
the idiotypic determinants nearly to that of the native molecule. 
The J.  T.  CLL cells were shown to possess the same antigenic determinants 
that  the paraprotein  possessed  including the idiotype (Table II). Virtually all 
cells possess a single heavy and light chain with a uniform idiotype. A variety of 
lymphocytes from normal donors and from other CLL patients all lacked the 
idiotypic determinants. The small fraction (0.3%) of 5-bearing lymphocytes in J. 
T.  cell preparations were shown to lack the idiotypic determinants by double- 
label immunofluorescence using Rh-anti-5 and Fl-anti-idiotype and presumably 
represent  normal  lymphocytes. Several  controls  indicated that  the  CLL cells 
produced the surface immunoglobulin rather than acquiring it passively from the 
serum. First, several control CLL suspensions were incubated at 37°C tor 12-18 h 
in J. T. serum and washed; no significant amounts of paraprotein were adsorbed, 
TABLE II 
Antigenic  Characteristics of J.  T.  CLL Surface Immunoglobulin 
Reagent  J.T. CLL  PBL  CLL 
Fl-anti-idiotype  91.4  < 1 (16) *  < 1 (23) * 
Fl-anti-~  92.4  11.3 (6)  ND 
Rh-anti-5  0.3  3.0  ND 
Fl-anti-a  <0.4  6.0  ND 
Rh-anti-tL  < 0.4  4.6  ND 
Fl-anti-¢  < 0.4  ND  ND 
Fl-anti-~  81.4  18.3  ND 
Fl-anti-),  < 0.2  7.8  ND 
* No. of individuals tested. 
as determined by Fl-anti-idiotype staining. Second,  culture of trypsinized (0.3 
mg trypsin/ml, 37 °C, 1 h) J. T. CLL cells for 6 h at 37 °C resulted in an increase in 
idiotype-bearing cells from 18% to 66% of viable cells. 
Discussion 
There  is  now considerable evidence for the  monoclonal nature of the cellular 
proliferation in  chronic lymphocytic leukemia (1).  In most studies, the surface 
immunoglobulin possesses a single light-chain type (1,  4, 5). Other instances of' 
restriction have been reported with regard to IgG subclasses and Gm allotypes 
(3). However, in all instances evidence of restriction has relied on markers in the 
constant regions  of Ig.  In  this  communication we  provide  evidence for clonal 
proliferation  by  demonstrating that  all  CLL cells  of a  single  patient  possess 
identical idiotypic (variable region) markers. The approach we used was similar 
to that of Kunkel and colleagues who showed that a substantial fraction of the 
lymphocytes of two individuals with apparently idiopathic [gM paraproteinemia 
possessed idiotypic determinants in common with their paraproteins (14). 
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single heavy-chain class,  two recent studies have shown that a  large fraction of 
patients with CLL possess cells bearing IgD in addition to IgM determinants (15, 
16).  While  J.  T.  CLL cells  under  consideration  in  this  study possessed only a 
single class of Ig, the use of anti-idiotypic sera should be especially valuable in 
the  study  of individual  cells  bearing Ig of more than  one  class  as  a  means  of 
proving variable region identity among the immunoglobulin classes. In summary, 
we have shown that the surface Ig on CLL lymphocytes of an individual patient 
possess common variable region markers, a finding which supports the thesis that 
the lymphoproliferation in CLL is monoclonal. 
We thank Doctors H. Metzgar, R. Wistar, and L. Claflin for their assistance with this study and Dr. 
E. Reinhard for permission to study his patients. 
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